Background
Pneumococcal disease remains a frequent bacterial infection in people with HIV (PWH). Considering available and upcoming pneumococcal vaccines, accurate knowledge of epidemiological trends and serotype distribution of pneumococcal disease in PWH is essential to guide prevention strategies.
Methods
We performed a retrospective cohort study of all culture-confirmed episodes of pneumococcal disease in PWH aged ≥18 years followed in our center from 2010 to 2024. Clinical data were extracted from medical records. Pneumococcal isolates were classified by serotype and Global Pneumococcal Sequence Cluster (GPSC). We used logistic regression with sandwich estimator to examine associations with invasive pneumococcal disease (IPD) and Poisson regression to assess temporal trends.
Results
A total of 119 episodes (29 IPD and 90 non-IPD) in 95 individuals were included. Median (Q1–Q3) age was 49 (42–55) years and 91 (76.5%) were assigned male at birth. History of injection drug use (76 [63.9%]), current tobacco use (87 [73.1%]), chronic lung disease (39 [32.8%]), and liver cirrhosis (13 [15.5%]) were common. At episode onset, 106 (89.1%) were on antiretroviral therapy, 83 (69.7%) had an undetectable viral load (VL), 80 (67.2%) had a CD4 count ≥200 cells/mm³, and 80 (67.2%) had been vaccinated with 23-valent polysaccharide vaccine (PPSV23) and/or 13-valent conjugate vaccine (PCV13).
IPD incidence decreased by 18.0% annually over the study period (IRR [95% CI] 0.82 [0.73–0.90]) and overall mortality was 17.2%. Detectable VL, CD4 count <200 cells/mm³, and lack of vaccination were associated with IPD (OR [95% CI] 3.52 [1.44–8.62], 2.43 [1.01–5.88], and 2.43 [1.01–5.88], respectively). Individuals with IPD had a higher risk of hospitalization and death (OR [95% CI] 5.02 [1.35–18.62] and 9.17 [1.62–51.88], respectively).
Serotypes 3 (13 [10.9%]), 19A (10 [8.4%]), and 11A (10 [8.4%]), and GPSC3 (9 [7.6%]) and GPSC12 (8 [6.7%]) were predominant. Global and period-specific distribution of isolate serotypes according to their inclusion in different vaccines is shown in Panels A and B, respectively. Vaccine failures occurred in 28/55 PPSV23 recipients in the previous 5 years and in 13/34 PCV13 recipients.
Conclusions
Although IPD incidence in PWH has decreased over the last 15 years, overall mortality remains high. Poor HIV control and lack of vaccination were the main factors associated with IPD. Our findings suggest that novel PCVs may cover a broader range of serotypes causing pneumococcal disease in PWH.
Table or Figure
